secwatch.observer — SEC 8-K summary
======================================

Issuer:     CorMedix Inc. (CRMD)
CIK:        0001410098
Form:       8-K
Filed at:   2026-08-07T20:18:31+00:00
Accession:  0001410098-26-000044
Event type: litigation
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CorMedix derivative suit settlement preliminarily approved; final hearing Sept 23, 2026
--------------------------------------------------------------------------------

- Court granted preliminary approval on July 24, 2026; final settlement hearing set for Sept 23, 2026 in Newark, NJ.
- Settlement requires corporate governance reforms maintained for 3.5 years; no monetary payment to stockholders.
- Plaintiffs' counsel may seek up to $3.9M in fees; defendants reserve right to oppose.
- Claims alleged fiduciary breaches over DefenCath manufacturing deficiencies and delayed FDA approval (2019-2022).
- Settlement resolves federal and state derivative actions; securities class action not part of this settlement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410098/000141009826000044/0001410098-26-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410098/000141009826000044/crmd-20260807.htm
  HTML page:      https://secwatch.observer/filing/0001410098-26-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer